← FDA Drug Approvals (Drugs@FDA)
MIFEPRISTONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2020-08-03
Drug application
- FDA Application #
ANDA211436- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MIFEPRISTONE
- Generic name
- MIFEPRISTONE
- Active ingredients
- MIFEPRISTONE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TEVA PHARMS USA INC
- Manufacturer
- Actavis Pharma, Inc.
- First approval
- 2020-08-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown